Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

Brain Research

Volumn 954, Issue 1, 2002, Pages 73-81

  González, Sara ^a   Grazia Cascio, Maria ^b   Fernández Ruiz, Javier ^a   Fezza, Filomena ^b   Di Marzo, Vincenzo ^b   Ramos, José A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CNR   (Italy)

Author keywords

Alcohol; CB1 receptor; Chronic drug exposure; Cocaine; Endocannabinoid; Nicotine

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ALCOHOL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; COCAINE; LIGAND; MESSENGER RNA; NICOTINE;

ALCOHOL CONSUMPTION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG USE; FOREBRAIN; HIPPOCAMPUS; LIMBIC CORTEX; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; ARACHIDONIC ACIDS; BINDING SITES; BRAIN; CANNABINOIDS; COCAINE; ENDOCANNABINOIDS; ETHANOL; GLYCERIDES; IN SITU HYBRIDIZATION; MALE; NICOTINE; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SUBSTANCE-RELATED DISORDERS;

EID: 0036838628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03344-9     Document Type: Article

References (66)

1. Arnold J.C., Topple A.N., Hunt G.E., McGregor I.S. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP55,940 on behavioral sensitization to cocaine. Eur. J. Pharmacol. 354:1998;9-16.
2. Arnone M., Maruani J., Chaperon F., Thiébot M.H., Poncelor M., Soubrié P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptors. Pyschopharmacology. 132:1997;104-106.
3. Basavarajappa B.S., Cooper T.B., Hungund B.L. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res. 79:1998;212-218.
4. 35S]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res. 815:1999;89-97.
5. Basavarajappa B.S., Hungund B.L. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. J. Neurochem. 72:1999;522-528.
6. Basavarajappa B.S., Saito M., Cooper T.B., Hungund B.L. Stimulation of cannabinoid receptor agonist 2-arachidonoylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim. Biophys. Acta. 1535:2000;78-86.
7. Bisogno T., Sepe N., Melck D., Maurelli S., De Petrocellis L., Di Marzo V. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J. 322:1997;671-677.
8. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J., Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 256:1999;377-380.
9. 1) receptors in the establishment of place conditioning in rats. Psychopharmacology. 135:1998;324-332.
10. Clementi F., Fornasari D., Gotti C. Neuronal nicotinic receptors, important new players in brain function. Eur. J. Pharmacol. 393:2000;3-10.
11. Colombo G., Agabio R., Fa M., Guano L., Lobina C., Loche A., Reali R., Gessa G.L. Reduction of voluntary ethanol intake in ethanol preferring SP by the cannabinoid antagonist SR141716. Alcohol Alcohol. 33:1998;126-130.
12. Comings D.E., Muhleman D., Gade R., Johnson P., Verde R., Saucier G., MacMurray J. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol. Psychiatry. 2:1997;161-168.
13. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 285:1998;1150-1156.
14. Cossu G., Ledent C., Fattore L., Imperato A., Böhme G.A., Parmentier M., Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118:2001;61-65.
15. De Petrocellis L., Melck D., Bisogno T., Milone A., Di Marzo V. Finding of endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience. 92:1999;377-387.
16. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J.M.J., Schoffelmeer A.N.M. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7:2001;1151-2254.
17. Deroche-Gamonet V., Le Moal M., Piazza P.V., Soubrie P. SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. Psychopharmacology. 157:2001;254-259.
18. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
19. Diana M., Melis M., Muntoni A.L., Gessa G.L. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc. Natl. Acad. Sci. USA. 95:1998;10269-10273.
20. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
21. 9-tetrahydrocannabinol-tolerant rats. J. Neurochem. 74:2000;1627-1635.
22. 1 cannabinoid receptor agonist WIN55,212-2 decreases intravenous cocaine self-administration in rats. Behav. Brain Res. 104:1999;141-148.
23. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., Nguyen D.N., Richardson J.M., Riggin R.M., Koppel G.A., Paul S.M., Becker G.W. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393:1996;231-235.
24. Fernández-Ruiz J.J., Berrendero F., Hernández M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23:2000;14-20.
25. Freedland C.S., Sharpe A.L., Samson H.H., Porrino L.J. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin. Exp. Res. 25:2001;277-282.
26. Fontana A., Di Marzo V., Cadas H., Piomelli D. Analysis of anandamide, an endogenous cannabinoid substance, and other natural N-acylethanolamines. Prostaglandins Leukot. Essent. Fatty Acids. 53:1995;301-308.
27. 1 receptor agonist. Eur. J. Pharmacol. 370:1999;233-240.
28. Gardner E.L., Vorel S.R. Cannabinoid transmission and reward-related events. Neurobiol. Dis. 5:1998;502-533.
29. Giorgetti M., Zhdanova I.V. Chronic cocaine treatment induces dysregulation in the circadian pattern of rats' feeding behavior. Brain Res. 877:2000;170-175.
30. González S., Fernández-Ruiz J.J., Sparpaglione V., Parolaro D., Ramos J.A. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcohol Depend. 66:2002;77-84.
31. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in situ autoradiographic study. J. Neurosci. 11:1991;563-583.
32. Hungund B.L., Basavarajappa B.S. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. Alcohol Alcohol. 35:2000;126-133.
33. Hungund B.L., Basavarajappa B.S. Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. J. Neurosci. Res. 60:2000;122-128.
34. 9-tetrahydrocannabinol. Br. J. Pharmacol. 125:1998;1567-1577.
35. Koga D., Santa T., Fukushima T., Homma H., Imai K. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues. J. Chromatogr. B Biomed. Sci. Appl. 690:1997;7-13.
36. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann. NY Acad. Sci. 909:2000;170-185.
37. Lallemand F., Soubrie P.H., De Witte P.H. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin. Exp. Res. 25:2001;1317-1323.
38. 1 receptor knockout mice. Science. 283:1999;401-404.
39. Lukas S.E., Sholar M., Kouri E., Fukuzako H., Mendelson J.H. Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. Pharmacol. Biochem. Behav. 48:1994;715-721.
40. 9-tetrahydrocannabinol and CP55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behav. Pharmacol. 5:1994;219-225.
41. Manzanares J., Corchero J., Romero J., Fernández-Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20:1999;287-294.
42. Martellota M.C., Cossu G., Fattore L., Gessa G.L., Fratta W. Self-administration of the cannabinoid receptor agonist WIN55,212-2 in drug-naive mice. Neuroscience. 85:1998;327-330.
43. 1 receptor knockout mice. Eur. J. Pharmacol. 383:1999;R1-R2.
44. McBride W.J., Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 12:1998;339-369.
45. 9-tetrahydrocannabinol or cocaine on ethanol intake in a rat model. Drug Alcohol Depend. 27:1991;263-274.
46. Miksys S., Hoffmann E., Tyndale R.F. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem. Pharmacol. 59:2000;1501-1511.
47. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, London.
48. Rezvani A.H., Levin E.D. Cognitive effects of nicotine. Biol. Psychiatry. 49:2001;258-267.
49. Rodríguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 276:1997;2050-2054.
50. 35S]GTPγS binding in morphine-dependent mice. Drug Alcohol Depend. 50:1998;241-249.
51. Romero J., Lastres-Becker I., de Miguel R., Berrendero F., Ramos J.A., Fernández-Ruiz J.J. The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological and therapeutic aspects. Pharmacol. Ther. 95:2002;137-152.
52. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP-55,940 alters cannabinoid receptor-mRNA in the rat brain: an in situ hybridization study. Neuroreport. 5:1994;2493-2496.
53. Rubino T., Tizzoni L., Vigano D., Massi P., Parolaro D. Modulation of rat brain cannabinoid receptors after chronic morphine treatment. Neuroreport. 8:1997;3219-3223.
54. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer T.M., Maasson J.L., Schmid H.H.O. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375:1995;117-120.
55. Serra S., Carai M.A., Brunetti G., Gómez R., Melis S., Vacca G., Colombo G., Gessa G.L. The cannabinoid receptor antagonist SR141716 prevents acquisition of drinking behavior in alcohol-preferring rats. Eur. J. Pharmacol. 430:2001;369-371.
56. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., Martin T.J. Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci. 20:2000;4555-4562.
57. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
58. Tanda G., Munzar P., Goldberg S.R. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3:2000;1073-1074.
59. Uzbay I.T., Usanmaz S.E., Akarsu E.S. Effects of chronic ethanol administration on serotonin metabolism in various regions of the rat brain. Neurochem. Res. 25:2000;257-262.
60. 9-tetrahydrocannabinol and nicotine. Br. J. Pharmacol. 135:2002;564-578.
61. Vela G., Ruiz-Gayo M., Fuentes J.A. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology. 34:1995;665-668.
62. 9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats. Brain Res. 807:1998;101-109.
63. D. Vigano, F. Fezza, M.G. Cascio, P. Massi, A. Vaccani, S. Romorini, V. Di Marzo, D. Parolaro, Reduction of endocannabinoid contents in several brain regions after chronic morphine treatment in rats. In: 2001 Symposium on the Cannabinoids, Burlington, VT. International Cannabinoid Research Society, 2001.
64. Walker J.M., Hohmann A.G., Martin W.J., Strangman N.M., Huang S.M., Tsou K. The neurobiology of cannabinoid analgesia. Life Sci. 65:1999;665-673.
65. Watkins S.S., Koob G.F., Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tobacco Res. 2:2000;19-37.
66. Yamamoto T., Takada K. Role of cannabinoid receptors in the brain as it relates to drug reward. Jpn. J. Pharmacol. 84:2000;229-236.